Periodic Reporting for period 1 - Nano-ImmunoEra (NANOTECHNOLOGY-ENABLED DETECTION OF CLINICALLY RELEVANT ANTIBODIES FOR EARLY CANCER DIAGNOSIS AND IMMUNOTHERAPY MONITORING)

Current methods for the quantitative detection of clinically-relevant antibodies mostly rely on enzyme linked immunosorbent assays (ELISAs), Western blots, and polarization assays, which are multistep, wash- and reagent-intensive processes that require sophisticated...